Lexicare Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Lexicare Pharma Private Limited, with the most recent activity at the t…

2011-02-17 Ankleshwar, Gujarat Active Unlisted Active Compliant
Share
Connect MCP
LP Lexicare Pharma Private Limited
Open charges
3
2.78 cr
Closed charges
1
50.00 Lakh
Total
4
3.28 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Axis Bank Limited 3 2.78 cr
2 Others 1 50.00 Lakh
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101137777 Axis Bank Limited 04 Aug 2025 - - 29.00 Lakh Open
101135089 Axis Bank Limited 30 Jul 2025 04 Aug 2025 - 1.53 cr Open
101135092 Axis Bank Limited 30 Jul 2025 04 Aug 2025 - 95.50 Lakh Open
100757250 Others 27 Jul 2023 - 28 Jul 2025 50.00 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Lexicare Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Lexicare Pharma Private Limited (CIN: U24230GJ2011PTC064061). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Lexicare Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.